Innoviva (INVA) Net Margin (2011 - 2026)
Innoviva posted quarterly Net Margin of 190.38% for Q1 2026, up 24295.0% year-on-year from N/an in Q1 2025, and up 114.94% on a QoQ basis from 1274.01% in Q4 2025.
Innoviva (INVA) has 16 years of Net Margin data on file, last reported at 190.38% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 24295.0% year-over-year to 190.38%; the trailing twelve-month figure through Mar 2026 stood at 106.25% (up 13869.0% YoY), and the FY2025 full-year result was 65.97%, up 5945.0% from the prior year.
- Net Margin for Q1 2026 stood at 190.38%, up from 1274.01% in the prior quarter.
- Across five years, Net Margin topped out at 20424.85% in Q3 2022 and bottomed at 1274.01% in Q4 2025.
- The 5-year median for Net Margin is 63.51% (2025), against an average of 1580.9%.
- The widest annual swing landed in 2022, when Net Margin soared 2035083 bps; it then sank 2030286 bps in 2023.
- A 5-year view of Net Margin shows it stood at 982.68% in 2022, then soared by 56 bps to 430.5% in 2023, then sank by 98 bps to 853.36% in 2024, then plunged by 49 bps to 1274.01% in 2025, then jumped by 115 bps to 190.38% in 2026.
- The last three Net Margin figures came in at 190.38% (Q1 2026), 1274.01% (Q4 2025), and 83.41% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 190.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190.38% |
| Dec 31, 2025 | -1,274.01% |
| Sep 30, 2025 | 83.41% |
| Jun 30, 2025 | 63.51% |
| Mar 31, 2025 | -52.56% |
| Dec 31, 2024 | -853.36% |
| Sep 30, 2024 | 1.36% |
| Jun 30, 2024 | -34.72% |
| Mar 31, 2024 | 3,780.95% |
| Dec 31, 2023 | -430.50% |
| Sep 30, 2023 | 121.99% |
| Jun 30, 2023 | 130.61% |
| Mar 31, 2023 | 4,380.03% |
| Dec 31, 2022 | -982.68% |
| Sep 30, 2022 | 20,424.85% |
| Jun 30, 2022 | 49.87% |
| Mar 31, 2022 | 1,276.13% |
| Dec 31, 2021 | -611.53% |
| Sep 30, 2021 | 74.02% |
| Jun 30, 2021 | 7,615.41% |
| Mar 31, 2021 | 8,829.55% |
| Dec 31, 2020 | 10,695.04% |
| Sep 30, 2020 | 31.82% |
| Jun 30, 2020 | 97.34% |
| Mar 31, 2020 | 83.17% |
| Dec 31, 2019 | 60.48% |
| Sep 30, 2019 | 60.54% |
| Jun 30, 2019 | 58.87% |
| Mar 31, 2019 | 61.23% |
| Dec 31, 2018 | 330.29% |
| Sep 30, 2018 | 76.34% |
| Jun 30, 2018 | 81.43% |
| Mar 31, 2018 | 56.47% |
| Dec 31, 2017 | 83.98% |
| Sep 30, 2017 | 48.86% |
| Jun 30, 2017 | 60.02% |
| Mar 31, 2017 | 41.60% |
| Dec 31, 2016 | 59.35% |
| Sep 30, 2016 | 45.13% |
| Jun 30, 2016 | 44.95% |
| Mar 31, 2016 | 18.34% |
| Dec 31, 2015 | 18.83% |
| Sep 30, 2015 | -33.80% |
| Jun 30, 2015 | -73.30% |
| Mar 31, 2015 | -154.68% |
| Dec 31, 2014 | -218.76% |
| Sep 30, 2014 | -2,129.23% |
| Jun 30, 2014 | -6,805.57% |
| Mar 31, 2014 | -8,679.87% |
| Dec 31, 2013 | -3,389.61% |
| Sep 30, 2013 | -11,321.69% |
| Jun 30, 2013 | -2,755.60% |
| Mar 31, 2013 | -2,826.02% |
| Dec 31, 2012 | 25.19% |
| Sep 30, 2012 | -2,426.01% |
| Jun 30, 2012 | -7,097.51% |
| Mar 31, 2012 | 67.24% |
| Dec 31, 2011 | -690.17% |
| Sep 30, 2011 | -476.22% |
| Jun 30, 2011 | -392.00% |
| Mar 31, 2011 | -358.03% |